RedCarpetLife
2245
In the world today
Samuel Chen

Samuel Chen

S. Chen
-0.06% | - $-1.14M
$1.78 B ₹ 16,184 Cr
Real Time Net Worth #2245 Ranking as of 21 Feb 2026 By Forbes

More on Samuel Chen

Gender

Male

Age

76Y

Country

Taiwan

Born On

January, 1950

Deceased

No

Relationship Status

Married

Children

2

Education

Unknown

Designation Info :

Self-Made

Yes

Entrepreneur Type

Self-Made (Investments)

Primary Organization

Digital Mobile Venture

Titles

Founder

Sources of Wealth

Zoom, Investments

Industry

Investments, Technology

About Samuel Chen


S amuel Chen is a Taiwanese billionaire investor best known for his astute early bet on Zoom Video Communications. He met Zoom founder Eric Yuan while playing soccer in California and became one of the first investors in the video conferencing platform. Chen's investment firm, Digital Mobile Venture, has backed numerous technology and biotech startups in Silicon Valley and Taiwan.

His initial wealth came from a successful business trading ink and consumables. Chen has a keen eye for high-growth potential companies and has served on the boards of several of his portfolio companies, including Zoom in its earlier years. He is also the majority owner of Polaris Group, a biopharmaceutical company focused on cancer treatments, which went public in Taiwan. His investment strategy blends technology with healthcare innovation.

Advertisement

Quick Reads


Early Life and Background


Samuel Chen is a Taiwanese businessman and self-made billionaire, known primarily as an early investor in Zoom. He made this investment after meeting founder Eric Yuan while playing football in San Francisco.

Chen earned his initial wealth by trading ink. He later founded the cancer drug research firm Polaris Group, which went public in Taiwan in 2022.

  • Core Company: Polaris Group (Cancer Drug Research).
  • Investment: Early investor in Zoom.
  • Initial Wealth: Earned by trading ink.

Career Journey of Samuel Chen


Samuel Chen’s career shifted from commodity trading (ink) to high-value technology and biotech investment. He was an early believer in Zoom, where he served as a director until 2018.

His structural contribution lies in funding and guiding technology and healthcare ventures. His own firm, Polaris Group, specializing in cancer drug research, successfully executed its IPO in Taiwan in 2022. He continues to invest in electronics and biotech through his Digital Mobile Venture.

Advertisement

Samuel Chen's Timeline


Pre-2000s:

Earned initial wealth by trading ink.

Ongoing:

Invested early in Zoom and cofounded Polaris Group.

2022:

Polaris Group executes its IPO in Taiwan.

2018:

Stepped down as a director of Zoom.

Major Business Ventures and Investments


Samuel Chen's wealth is concentrated in his biotech company, Polaris, and his highly profitable early technology investments.

  • Polaris Group (Founder): Cancer drug research firm that went public in Taiwan in 2022.
  • Zoom (Early Investor & Former Director): Made a major fortune on his early investment in the video conferencing platform.
  • Investment Strategy: Focuses on biotech and electronics companies in Taiwan through Digital Mobile Venture.

Advertisement

Philanthropy and Social Impact


Fashion, Style, and Lifestyle


Advertisement

Quotes and Philosophy


No publicly available quotes.

Fun Facts & Trivia


  • He made his first fortune by trading ink.
  • He was an early investor in Zoom, meeting founder Eric Yuan while playing football.
  • He founded the cancer drug research firm Polaris Group, which went public in Taiwan in 2022.

Advertisement

More Profiles


Philip Anschutz

+15.01% | +$2.53B

Doug Ostrover

-2.53% | -$58.82M

You May Like


Sources & References


This profile is compiled from verified biographical and financial records:

  • Wealth Data: Real-time tracking and historical data from Forbes Billionaires and the Bloomberg Billionaires Index.
  • Biographical Records: Educational and career history sourced from Reuters, The Wall Street Journal, and official university alumni directories.
  • Regulatory Filings: Shareholder and executive disclosures from stock exchange databases, including HKEX, SSE, SZSE, and SEC EDGAR.
  • Corporate History: Primary data from annual company reports, founding charters, and verified press announcements.

All information is cross-referenced with public sources for accuracy; some narrative sections are AI-assisted summaries.

If you find any inaccuracies, please report them to admin@redcarpetlife.in

Sponsored Content